These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3190812)

  • 1. A novel approach to the specification of in-vitro dissolution boundaries based on regulatory requirements for bioequivalence.
    Steinijans VW; Dietrich R; Trautmann H; Sauter R; Benedikt G
    Arzneimittelforschung; 1988 Aug; 38(8A):1238-40. PubMed ID: 3190812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vivo verification of in vitro release specifications of a theophylline sustained-release preparation].
    von Nieciecki A; Fuchs WS; Pabst G; Müller M; Dilger C; Gay S; Laicher A; Stanislaus F
    Arzneimittelforschung; 1998 May; 48(5A):580-3. PubMed ID: 9676348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics of a new fluid theophylline sustained-release drug form. Microcapsules in a sachet].
    Fuchs WS; Weiss G; von Nieciecki A; Laicher A; Gay S; Pabst G; Müller M
    Arzneimittelforschung; 1998 May; 48(5A):612-7. PubMed ID: 9676354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic characteristics of a new liquid sustained-release formulation of theophylline designed for the elderly and children: microcaps as sachet.
    Fuchs WS; Weiss G; Von Nieciecki A; Laicher A; Gay S; Pabst G; Müller M
    Int J Clin Pharmacol Ther; 1996 Dec; 34(12):558-63. PubMed ID: 8996853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The bioequivalence of two different batches of two nifedipine controlled-release preparations with deficient batch conformity in in vitro liberation studies].
    Theiss U; Gebhardt E; Müller J
    Arzneimittelforschung; 1992 May; 42(5):629-32. PubMed ID: 1530675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Requirements for product quality of theophylline sustained-release preparations].
    Fuchs WS; Hens C; von Nieciecki A
    Arzneimittelforschung; 1998 May; 48(5A):556-61. PubMed ID: 9676344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of in-vitro/in-vivo correlation in the case of a new sustained-release theophylline pellet formulation.
    Dietrich R; Brausse R; Benedikt G; Steinijans VW
    Arzneimittelforschung; 1988 Aug; 38(8A):1229-37. PubMed ID: 3190811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Manufacture and in vitro characterization of a new fluid theophylline sustained-release form. Sachets with microcapsules for administration in a drinkable sustained-release suspension].
    Weiss G; Klemm FH; Fuchs WS; Stanislaus F; Zema M; Calanchi M
    Arzneimittelforschung; 1998 May; 48(5A):604-12. PubMed ID: 9676353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.
    González MA; Straughan AB
    Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galenical development of a new sustained-release theophylline pellet formulation for once-daily administration.
    Benedikt G; Steinijans VW; Dietrich R
    Arzneimittelforschung; 1988 Aug; 38(8A):1203-9. PubMed ID: 3190808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPLC analysis of theophylline: bioequivalence study of two sustained-release formulations at steady state.
    Mazzei M; Sottofattori E; Balbi A; Bottino GB
    Farmaco; 1992 May; 47(5 Suppl):769-77. PubMed ID: 1524625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Revalidation of the in vitro specification limits after an in vitro-in vivo correlation].
    Pabst G
    Arzneimittelforschung; 1998 May; 48(5A):584-8. PubMed ID: 9676349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the in-vitro dissolution method used for a new sustained-release theophylline pellet formulation.
    Dietrich R; Brausse R; Bautz A; Diletti E
    Arzneimittelforschung; 1988 Aug; 38(8A):1220-8. PubMed ID: 3190810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic profile of a new sustained-release theophylline pellet formulation for once-daily evening administration.
    Steinijans VW; Sauter R; Böhm A; Staudinger H
    Arzneimittelforschung; 1988 Aug; 38(8A):1241-50. PubMed ID: 3190813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single dose study of the bioequivalence of two sustained-release theophylline formulations.
    Contreras J; Pérez N; González R; Ontivero E; López M
    Arzneimittelforschung; 1998 Mar; 48(3):259-62. PubMed ID: 9553683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absorption of theophylline from a sustained-release theophylline tablet formulation, Theo-Dur.
    Takagi K; Hasegawa T; Ogura Y; Yamaki K; Suzuki R; Satake T; Imaeda N; Mizukami Y
    Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):530-5. PubMed ID: 3429057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioequivalence studies: single vs multiple dose.
    Steinijans VW; Sauter R; Jonkman JH; Schulz HU; Stricker H; Blume H
    Int J Clin Pharmacol Ther Toxicol; 1989 May; 27(5):261-6. PubMed ID: 2737794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining level A IVIVC dissolution specifications based on individual in vitro dissolution profiles of a controlled release formulation.
    González-García I; García-Arieta A; Merino-Sanjuan M; Mangas-Sanjuan V; Bermejo M
    Eur J Pharm Sci; 2018 Jul; 119():200-207. PubMed ID: 29680456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PK/PD modelling of high-dose diltiazem--absorption-rate dependency of the hysteresis loop.
    Luckow V; Della Paschoa O
    Int J Clin Pharmacol Ther; 1997 Oct; 35(10):418-25. PubMed ID: 9352390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.